Perforation of small intestinal metastasis of lung adenocarcinoma treated with pembrolizumab: a case report

BACKGROUND: Pembrolizumab is an immune checkpoint inhibitor and is an anti-human programmed cell death-1 (PD-1) monoclonal antibody. Pembrolizumab is used for non-small cell lung carcinoma with high programmed cell death ligand-1 (PD-L1) expression. It has been found that better overall survival can...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Surg Case Rep
Päätekijät: Sato, Shoki, Senmaru, Naoto, Ishido, Keita, Saito, Takahiro, Poudel, Saseem, Muto, Jun, Syouji, Yasuhito, Hase, Ryunosuke, Hirano, Satoshi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2019
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6821905/
https://ncbi.nlm.nih.gov/pubmed/31667679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-019-0730-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia